ÂÜŔňÂŇÂ×

The Board of Directors at LEXEO Therapeutics provides strategic oversight, governance, and direction to ensure the company effectively leverages its gene therapy pipeline to tackle genetic and acquired diseases. Comprised of experienced industry leaders, the board is responsible for making high-level policy decisions, guiding corporate strategy, and ensuring regulatory compliance to advance LEXEO’s mission.